Opening book details…
Can I read Safety and Efficacy of Initializing the Control-IQ Artificial Pancreas System Based on Total Daily Insulin in Adolescents with Type 1 Diabetes on EtoBox?
Safety and Efficacy of Initializing the Control-IQ Artificial Pancreas System Based on Total Daily Insulin in Adolescents with Type 1 Diabetes by Melissa J. Schoelwer; Jessica L. Robic; Thibault Gautier; Chiara Fabris; Kelly Carr; Mary Clancy-Oliveri; Sue A. Brown; Stacey M. Anderson; Mark D. DeBoer; Daniel R. Cherñavvsky; Marc D. Breton is a Medicine article available to read on EtoBox.
What is Safety and Efficacy of Initializing the Control-IQ Artificial Pancreas System Based on Total Daily Insulin in Adolescents with Type 1 Diabetes about?
To assess the safety and efficacy of a simplified initialization for the Tandem t:slim X2 Control-IQ hybrid closed-loop system, using parameters based on total daily insulin ("MyTDI") in adolescents with type 1 diabetes under usual activity and during periods of increased exercise. Adolescents with type 1 diabetes 12-18 years of age used Control-IQ for 5 days at home using their usual parameters. Upon arrival at a 60-h ski camp, participants were randomized to either continue Control-IQ using their home settings or to reinitialize Control-IQ with MyTDI parameters. Control-IQ use continued for 5 days following camp. The effect of MyTDI on continuous glucose monitoring outcomes were analyzed using repeated measures analysis of variance (ANOVA): baseline, camp, and at home. Twenty participants were enrolled and completed the study; two participants were excluded from the analysis due to absence from ski camp (1) and illness (1). Time in range was similar between both groups at home and camp. A tendency to higher time 40% tended to show greater time in the euglycemic range improvements between baseline and home than users with ratios <40% (+16.3% vs. -9.0%, = 0.012). All participants
Who reads Safety and Efficacy of Initializing the Control-IQ Artificial Pancreas System Based on Total Daily Insulin in Adolescents with Type 1 Diabetes?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Melissa J. Schoelwer; Jessica L. Robic; Thibault Gautier; Chiara Fabris; Kelly Carr; Mary Clancy-Oliveri; Sue A. Brown; Stacey M. Anderson; Mark D. DeBoer; Daniel R. Cherñavvsky; Marc D. Breton
- Publisher
- Mary Ann Liebert; Mary Ann Liebert Inc.; Mary Ann Liebert Inc (ISSN 1520-9156)
- Published
- 2020
- Language
- EN
- Field
- Medicine (Health Sciences)